Jean-Luc PASQUIE

Jean-Luc PASQUIE

orcid

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 October 2020 in Circulation
Verified
Journal Article
Closed access
PDF file
VWVictor Waldmann
Victor Waldmann
ABAbdeslam Bouzeman
Abdeslam Bouzeman
GDGuillaume Duthoit
Guillaume Duthoit
LKLinda Koutbi
Linda Koutbi
FBFrancis Bessiere
Francis Bessiere
MHMélèze Hocini
Mélèze Hocini
Background: Tetralogy of Fallot (TOF) is the most common cyanotic congenital heart disease, and sudden cardiac death represents an important mode of death in these patients. Data evaluating the implantable cardioverter defibrillator (ICD) in this patient population remain scarce. Methods: A Nationwide French Registry including all patients with tetralogy of Fallot with an ICD was initiated in 2010 by the French Institute of Health and Medical Research. The primary time to event end point was the time from ICD implantation to first appropriate ICD therapy. Secondary outcomes included ICD-related complications, heart transplantation, and death. Clinical events were centrally adjudicated by a blinded committee. Results: A total of 165 patients (mean age, 42.2±13.3 years, 70.1% males) were included from 40 centers, including 104 (63.0%) in secondary prevention. During a median (interquartile range) follow-up of 6.8 (2.5–11.4) years, 78 (47.3%) patients received at least 1 appropriate ICD therapy. The annual incidence of the primary outcome was 10.5% (7.1% and 12.5% in primary and secondary prevention, respectively; P =0.03). Overall, 71 (43.0%) patients presented with at least 1 ICD complication, including inappropriate shocks in 42 (25.5%) patients and lead dysfunction in 36 (21.8%) patients. Among 61 (37.0%) patients in primary prevention, the annual rate of appropriate ICD therapies was 4.1%, 5.3%, 9.5%, and 13.3% in patients with, respectively, 0, 1, 2, or ≥3 guidelines-recommended risk factors. QRS fragmentation was the only independent predictor of appropriate ICD therapies (hazard ratio, 3.47 [95% CI, 1.19–10.11]), and its integration in a model with current criteria increased the 5-year time-dependent area under the curve from 0.68 to 0.81 ( P =0.006). Patients with congestive heart failure or reduced left ventricular ejection fraction had a higher risk of nonarrhythmic death or heart transplantation (hazard ratio, 11.01 [95% CI, 2.96–40.95]). Conclusions: Patients with tetralogy of Fallot and an ICD experience high rates of appropriate therapies, including those implanted in primary prevention. The considerable long-term burden of ICD-related complications, however, underlines the need for careful candidate selection. A combination of easy-to-use criteria including QRS fragmentation might improve risk stratification. Registration: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT03837574.

28 October 2004 in Journal of Cardiovascular Electrophysiology
Verified
Journal Article
Closed access
PDF file
JPJean-Luc PASQUIE
Jean-Luc PASQUIE
PSPrashanthan Sanders
Prashanthan Sanders
MHMélèze Hocini
Mélèze Hocini
LHLi Fern Hsu
Li Fern Hsu
CSChristophe Scavée
Christophe Scavée
MHMichel Haïssaguerre
Michel Haïssaguerre

25 November 2022 in Cells
Verified
Journal Article
Open access
PDF file
ABAlbin Auguste Bernardin
Albin Auguste Bernardin
SCSarah Colombani
Sarah Colombani
ARAntoine Rousselot
Antoine Rousselot
VAVirginie Andry
Virginie Andry
YGYannick Goumon
Yannick Goumon
AMAlbano Meli
Albano Meli
In the heart, cardiac function is regulated by the autonomic nervous system (ANS) that extends through the myocardium and establishes junctions at the sinus node and ventricular levels. Thus, an increase or decrease in neuronal activity acutely affects myocardial function and chronically affects its structure through remodeling processes. The neuro–cardiac junction (NCJ), which is the major structure of this system, is poorly understood and only a few cell models allow us to study it. Here, we present an innovant neuro–cardiac organ-on-chip model to study this structure to better understand the mechanisms involved in the establishment of NCJ. To create such a system, we used microfluidic devices composed of two separate cell culture compartments interconnected by asymmetric microchannels. Rat PC12 cells were differentiated to recapitulate the characteristics of sympathetic neurons, and cultivated with cardiomyocytes derived from human induced pluripotent stem cells (hiPSC). We confirmed the presence of a specialized structure between the two cell types that allows neuromodulation and observed that the neuronal stimulation impacts the excitation–contraction coupling properties including the intracellular calcium handling. Finally, we also co-cultivated human neurons (hiPSC-NRs) with human cardiomyocytes (hiPSC-CMs), both obtained from the same hiPSC line. Hence, we have developed a neuro–cardiac compartmentalized in vitro model system that allows us to recapitulate the structural and functional properties of the neuro–cardiac junction and that can also be used to better understand the interaction between the heart and brain in humans, as well as to evaluate the impact of drugs on a reconstructed human neuro–cardiac system.

10 January 2006 in EP Europace
Verified
Journal Article
Open access
PDF file
JPJean-Luc PASQUIE
Jean-Luc PASQUIE
JSJoseph Scalzi
Joseph Scalzi
JMJean Christophe Macia
Jean Christophe Macia
FLFlorence Leclercq
Florence Leclercq
RGRobert Grolleau-Raoux
Robert Grolleau-Raoux
The association of atrioventricular nodal re-entrant tachycardia (AVNRT) and pre-existing prolonged PR interval is unusual. Radiofrequency (RF) ablation in such patients may be associated with an increased risk of immediate and delayed AV block. The aim of our study is to assess the long-term efficacy and safety of slow pathway ablation in this population. We studied 10 patients (4 males and 6 females) with pre-existing prolonged PR interval of 68 consecutive patients with AVNRT. All had slow–fast subtype of AVNRT. The mean PR interval was 222±15 ms before RF. The patients with pre-existing prolonged PR were older (69±15 vs. 54±17, P=0.008) and their tachycardias were slower (387±102 vs. 323±73 ms; P<0.05). Transient complete AV block (<5 s) occurred in two patients. None had permanent complete AV block. One patient had a significant increase in PR interval (from 220 to 320 ms). The mean post-RF PR interval was 232±37 ms (P=n.s.). Over a mean follow-up of 39±21 months, none had a recurrence of tachycardia nor developed higher degree AV block. In conclusion, in patients with AVNRT and pre-existing prolonged PR interval, a slow pathway ablation appeared efficient and safe. From our data, no delayed AV block developed on a long follow-up. Most of the patients with periprocedural transient AV block had no evidence of dual AV node physiology, suggesting that, in this population, absence of dual AV node physiology may be associated with a higher risk of AV block during slow pathway ablation.

18 January 2007 in Pacing and Clinical Electrophysiology
Verified
Journal Article
Closed access
PDF file
JPJean-Luc PASQUIE
Jean-Luc PASQUIE
FMF. Massin
F. Massin
JMJ.C. Macia
J.C. Macia
RGR. Gervasoni
R. Gervasoni
ABA. Bortone
A. Bortone
FLF. Leclercq
F. Leclercq

28 February 2010 in Annales de Cardiologie et d'Angéiologie
Verified
Journal Article
Closed access
SMS. Machado
S. Machado
FRFrançois Roubille
François Roubille
GGG. Gahide
G. Gahide
HKHélène Kovacsik
Hélène Kovacsik
LCL. Cornillet
L. Cornillet
FLF. Leclercq
F. Leclercq